Indefinite Delivery Contract 75N93025D00001

Award Date 10/13/24
Last Date to Order 10/12/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Time and Materials
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded an indefinite-delivery, indefinite-quantity (IDIQ) contract valued at up to $3.8M to Envision Now, LLC, an SBA-certified 8(a) and HUBZone small business, for office and laboratory relocation services. Under this single-award IDIQ, Envision Now has received over a dozen delivery orders ranging from $2,000 to $839,000 to provide services...
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to The Emmes Company LLC on September 1, 2021. With a potential value of $545,452,906 over seven years, this single award IDC supports NIAID's research programs through a broad range of services. Task Order 1 issued under the contract is a firm fixed price order valued at $2,000 to satisfy minimum requirements. Performance will take place in Potomac, MD from September 1, 2021 through August 31,...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, awarded a $146.3 million Indefinite Delivery Contract (IDC) to Institute For Clinical Pharmacodynamics, Inc., a for-profit organization, to provide pre-clinical models of infectious diseases under Task Area C. The period of performance is from July 15, 2024 to July 14, 2031. The contract is a follow-on to a previous Preclinical Models of Infectious Diseases...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded an $80 million Indefinite Delivery Contract (IDC) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for preclinical models of infectious diseases research from 2017 to 2024. LBERI, doing business as Inhalation Toxicology Research Institute, is a non-profit contract research organization that provides expertise in areas such as inhalation toxicology, infectious disease modeling, and medical...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, awarded a multiple award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide preclinical development support for candidate products and drug development activities ranging from initial product discovery to activities required for clinical trials and product licensure. The $107.3 million contract has a 7-year period of performance from...
The federal contract IDV award is for an Indefinite Delivery Contract with a ceiling value of $146,300,000 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is focused on providing pre-clinical models of infectious diseases to support research, development, and evaluation of medical countermeasures such as therapeutics, vaccines, and diagnostics. The contract has a single award to...
The Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $9.85 million single-award Indefinite Delivery Contract to Lumina Corps Inc., a woman-owned small business, to provide specialized logistical, meeting, and conference support services in support of infectious disease research through March 2028. This contract encompasses two main components: Logistical Support Services, which include...
  • 75N93025D00001
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) to Envision Now, LLC, a small business specializing in facility support and relocation services. The single-award, 8(a) set-aside IDC has a ceiling value of $4,500,000 and a period of performance through October 2027. The contract is for office and laboratory relocation services to support NIAID's ongoing research mission in infectious diseases and immunology. Under this IDC, NIAID has issued two delivery orders to Envision Now valued at $1,269,675.59 and $1,348,251.94, respectively, for time and materials-based relocation support. The flexibility of this IDC vehicle allows NIAID to quickly obtain Envision Now's services for both planned renovations and ad-hoc relocation needs across NIAID's research campuses.

Envision Now, an Economically Disadvantaged Women-Owned Small Business (EDWOSB) and 8(a) Program participant, has a strong track record of supporting NIAID and other HHS components through similar facility support and relocation contracts. The company's services include office and laboratory moves, equipment relocations, space reconfigurations, storage and logistics, and furniture procurement. This IDC and associated task orders enable NIAID to efficiently access Envision Now's specialized expertise to ensure the continuity of its critical infectious disease and immunology research operations.

Generated 11/19/24, 9:06 AM